Lv53
870 积分 2025-04-28 加入
Noncoding regions are the main source of targetable tumor-specific antigens
1天前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
2天前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
2天前
已完结
Specifically Enhanced Immunosuppression of B Cells with Chimeric Antigen Receptors Modify Mesenchymal Stem Cells
7天前
已完结
Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides
8天前
已完结
T cell-based cancer immunotherapy: opportunities and challenges
9天前
已完结
Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy
16天前
已完结
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
22天前
已完结
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1
26天前
已完结
From TCR fundamental research to innovative chimeric antigen receptor design
27天前
已完结
皖公网安备34019202002308
